Breaking NewsAlphagreen To Raise £2m Growth Funding At A Valuation...

Alphagreen To Raise £2m Growth Funding At A Valuation Of £10m

-

FAST-growing UK CBD, health and medical cannabis business the Alphagreen Group has launched £2m funding round with half of the fund-raise set to come from the Seedrs investment platform.

Alphagreen’s growth has been rapid with its initial B2C CBD marketplace now hosting over 150 brands as it expands its presence across Europe and into Asia.

It also recently launched the Nuoptima B2B platform featuring SEO ranking, social influencer, AdWords, email marketing, and cross-border distribution, with others, set to follow.

CEO & Co-Founder of Alexej Pikovsky said it is raising the cash based on a valuation of £10m with the £2m to be used used across its business streams.

He said: “The funds will be used to boost our international growth, continue our work with the best global brands, roll-out our business intelligence and growth platform and enter the medical cannabis space.”

Alphagreen CBD

Mr Pikovsky said Alphagreen had been contemplating a number of fund-raising avenues before settling on a private fund-raise, alongside Seedrs.

He said: “It’s a nice alternative to the public markets as you can also trade your investments on the Seedrs Secondary Market and it will allow us to continue to build our business in a long-term, sustainable way.”

The London-based Seedrs platform has some 500,000 active investors and taps into the emerging appetite for individual investment amongst a younger demographic.

Alphagreen.io is one of Europe’s leading CBD marketplaces and currently hosts 2,500 products and 150-plus brands. It has a presence in Germany and Sweden, Spain, Italy and France and Poland, with Hong Kong and Japan set to follow.

Writing on LinkedIn Mr Pikovsky said: “We’re crowdfunding one of the biggest rounds in the health space this year! Become an investor in Alphagreen and be part of the revolution.”

The Alphagreen Group also operates a German subsidiary for the import and distribution of medical cannabis.


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Why Can CBD Be A ‘Cure-For-All’ In Europe – But Not The United States?

By Liebe Griebenauw and Peter McCusker FOUR firms have been sanctioned in the latest crackdown by the United States Food...

Markets: PepsiCo Launches German Hemp Drink, Curaleaf’s $130m Backer, Organigram, Canopy Growth, Fyllo et al…

FOLLOWING its recent purchase of UK cannabis firm EMMAC Life Sciences, Curaleaf has now secured an additional $130m from...

Euro Cannabis Leader Alfredo Pascual To Join UK Investor With £12m-Plus To Deploy

UK investment fund Fast Forward Innovations has added Alfredo Pascual - one of Europe’s leading cannabis industry figures -...

Love Hemp Raises £5m With A London Stock Exchange Flotation In Sight

FAST-GROWING UK CBD business Love Hemp has unveiled plans to list on the London Stock Exchange backed by an...

CBD Marketplace Mellow Expanding Rapidly With New B2B and B2C Offerings

THE marketplace entrepreneurs behind the mellow platform are diversifying with the launch of a new e-commerce service for partner...

Dutch/Canadian Duopoly In European Medicinal Cannabis Market In Retreat

THE European medicinal cannabis supply stranglehold once enjoyed by Canada and the Netherlands is being disrupted, concludes Prohibition Partners...

Must read

Why Can CBD Be A ‘Cure-For-All’ In Europe – But Not The United States?

By Liebe Griebenauw and Peter McCusker FOUR firms have been...

Euro Cannabis Leader Alfredo Pascual To Join UK Investor With £12m-Plus To Deploy

UK investment fund Fast Forward Innovations has added Alfredo...

You might also likeRELATED
Recommended to you